Delivery Order 36F79720D0136-36C24526N0103
Award Date 10/17/25
Potential Completion Date 10/21/25
Potential Value $46K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Carrollton, TX 75010, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Veterans Affairs Veterans Health Administration awarded a delivery order contract to Ferring Pharmaceuticals Inc., a for-profit manufacturer, to provide the oncology medication Adstiladrin (nadofaragene firadenovec) under the agency's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract. The $45,829.15 firm-fixed price order is for delivery by December 31, 2024 to support the VA's provision of healthcare services to veterans through its integrated network of...
- Ferring Pharmaceuticals Inc. has received a $45,829.15 delivery order from the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 16 to supply the oncology medication Nadofaragene Firadenovec, trade name Adstiladrin, for delivery to a location in Carrollton, Texas by March 30, 2024. This delivery order was issued against Ferring's existing Pharmaceuticals and Drugs Federal Supply Schedule contract with the VA, which has a potential value of $98.2...
- This is a delivery order awarded by the U.S. Department of Veterans Affairs (VA) to Ferring Pharmaceuticals Inc., a for-profit pharmaceutical manufacturer, for the provision of the bladder cancer drug Adstiladrin (nadofaragene firadenovec). The $274,974.90 firm-fixed-price order was placed against Ferring's existing multiple-award indefinite-delivery vehicle (IDV) on the VA's Federal Supply Schedule (FSS-61-IB) for Pharmaceuticals and Drugs, which has a total potential value of $98.2 million...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2 awarded a $91,658.30 firm fixed price delivery order against the Pharmaceuticals and Drugs GSA Schedule to Ferring Pharmaceuticals Inc. for the provision of Nadofaragene Firadenovec, also known as Adstiladrin, to be delivered between November 13 and December 13, 2023 at the prime contractor's location in Parsippany, New Jersey. As the lead agency for providing healthcare services to...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 awarded a $45,829.15 firm fixed price delivery order contract to Ferring Pharmaceuticals Inc. under the company's Pharmaceuticals and Drugs Federal Supply Schedule contract. The contract is for the emergency procurement of Adstiladrin to be delivered to a location in Carrollton, Texas between November 8 and December 7, 2023. No set aside designation or subcontractors were indicated. The...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20 awarded Ferring Pharmaceuticals Inc. a $45,829.15 firm fixed price delivery order against the company's GSA Schedule Pharmaceuticals and Drugs contract. The order is for the delivery of NADOFARAGENE FIRADENOVEC-VNCG SUSP,INTRAVESICAL to locations in Parsippany, New Jersey between December 2023 and April 2024. No subcontractors or set aside designations were identified. This award will provide...
- The Department of Veterans Affairs Veterans Health Administration awarded a $91,658 delivery order against the Pharmaceuticals and Drugs GSA Schedule to Ferring Pharmaceuticals Inc. to supply ADTILADRIN. The contract has a period of performance from November 7 to December 7, 2023 for Veterans Integrated Service Network 10. Ferring Pharmaceuticals will fulfill the order for the unidentified pharmaceutical product from its location in Parsippany, New Jersey under firm fixed pricing terms to...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17 awarded a $45,829.15 firm fixed price purchase order to ASD Specialty Healthcare, LLC for the delivery of Adstiladrin Nadofaragene Firadenovec-VNCG. ASD Specialty Healthcare, LLC will perform as the prime contractor, operating from its location in Carrollton, Texas. The contract period of performance spans from November 22, 2023 to January 5, 2024. No set-aside designation or subcontractors...
- This is a firm fixed-price delivery order awarded by the Department of Veterans Affairs (VA) to Novartis Pharmaceuticals Corporation, a large foreign-owned pharmaceutical manufacturer. The contract is for the drug Fabhalta 200 mg, with a ceiling value of $33,838.23 and an ultimate completion date of August 7, 2025. The contract was awarded on August 4, 2025 and does not have a set-aside designation. Novartis holds two significant federal contract vehicles with the VA - a $21.5 million Blanket...
- This is a firm fixed price delivery order awarded by the U.S. Department of Veterans Affairs (VA) to Janssen Biotech Inc., doing business as Centocor Ortho Biotech Inc. The order is valued at $18,125.50 and provides the VA's Veterans Health Administration (VHA) with the oncology medication BALVERSA (erdafitinib) to support healthcare services for veterans. The delivery order is placed against Janssen Biotech's existing $3.1 billion Federal Supply Schedule (FSS) contract for Pharmaceuticals and...